Clinical Research Directory
Browse clinical research sites, groups, and studies.
Autologous Stem Cell Therapy in Patients With Multiple System Atrophy
Sponsor: Biocells Medical
Summary
This study investigates the safety and efficacy of autologous stem cell therapy in patients with Multiple System Atrophy (MSA), a rare and progressive neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. The trial will evaluate functional outcomes, motor performance, and quality of life compared to placebo/controlled group.
Official title: A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Autologous Stem Cell Therapy in Patients With Multiple System Atrophy
Key Details
Gender
All
Age Range
35 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2026-09-01
Completion Date
2031-03-01
Last Updated
2026-03-11
Healthy Volunteers
No
Conditions
Interventions
MSCs
IV infusion of 200,000,000 of neuroinduced mesynchimal stem cells at week 1 of the trial period
Placebo
Intravenous 0.9% saline infusion, volume- and appearance-matched
Locations (1)
BioCells Medical
Warsaw, Poland